Technical Analysis for ENTA - Enanta Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade B 100.52 -1.92% -1.97
ENTA closed down 1.92 percent on Tuesday, May 22, 2018, on 1.24 times normal volume.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical ENTA trend table...

Date Alert Name Type % Chg
May 22 Multiple of Ten Bullish Other 0.00%
May 22 Down 3 Days in a Row Weakness 0.00%
May 21 MACD Bearish Signal Line Cross Bearish -1.92%
May 21 Stochastic Sell Signal Bearish -1.92%
May 21 Slingshot Bullish Bullish Swing Setup -1.92%
May 21 Overbought Stochastic Strength -1.92%
May 18 Bearish Engulfing Bearish -3.73%
May 18 New 52 Week High Strength -3.73%
May 18 Overbought Stochastic Strength -3.73%
May 17 New 52 Week Closing High Bullish -5.28%

Older signals for ENTA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Enanta Pharmaceuticals, Inc., a biotechnology company, engages in the development of small molecule drugs for the infectious disease areas. Its product candidates include ABT-450, an inhibitor of NS3 protease that is in Phase III clinical trials for the treatment of hepatitis C virus (HCV) infection; EDP-239, an NS5A Inhibitor for HCV infection; EDP-546, a Cyclophilin inhibitor, which is in preclinical studies for HCV infection treatment; and Nucleotide Polymerase inhibitor for HCV infection. The company also develops EDP-788, an intravenous drug for the treatment of methicillin-resistant Staphylococcus aureus bacteria. It has collaboration and license agreements with Novartis Institutes for BioMedical Research, Inc. and Abbott Laboratories. The company was founded in 1995 and is headquartered in Watertown, Massachusetts.
Is ENTA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 108.0
52 Week Low 29.46
Average Volume 173,359
200-Day Moving Average 64.6437
50-Day Moving Average 90.6846
20-Day Moving Average 99.587
10-Day Moving Average 102.365
Average True Range 3.8274
ADX 18.59
+DI 25.97
-DI 25.08
Chandelier Exit (Long, 3 ATRs ) 96.5178
Chandelier Exit (Short, 3 ATRs ) 97.1822
Upper Bollinger Band 109.3706
Lower Bollinger Band 89.8034
Percent B (%b) 0.55
BandWidth 19.648348
MACD Line 3.9947
MACD Signal Line 4.3419
MACD Histogram -0.3472
Fundamentals Value
Market Cap 1.92 Billion
Num Shares 19.1 Million
EPS -1.08
Price-to-Earnings (P/E) Ratio -93.07
Price-to-Sales 23.12
Price-to-Book 3.52
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 105.73
Resistance 3 (R3) 106.08 104.70 104.86
Resistance 2 (R2) 104.70 103.37 104.52 104.57
Resistance 1 (R1) 102.61 102.56 101.92 102.26 104.28
Pivot Point 101.23 101.23 100.89 101.05 101.23
Support 1 (S1) 99.14 99.90 98.45 98.79 96.76
Support 2 (S2) 97.76 99.09 97.58 96.47
Support 3 (S3) 95.67 97.76 96.18
Support 4 (S4) 95.32